Fondazione Piemontese per la Ricerca sul Cancro Onlus

Recent papers from Fondazione Piemontese per la Ricerca sul Cancro Onlus

1. Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular LymphomaBlood Advances · 2026
2. Unlocking Bioactive, Peptide-Rich Extracts from Tomato Seeds Using Enzymatic-Assisted ExtractionFoods · 2026
3. Extracellular Vesicle-Associated miR-222-3p and miR-186-5p as Potential Hypoxic Markers in Canine Osteosarcoma: A Preliminary In Vitro StudyAnimals · 2026
4. Abstract 776: A cancer cell intrinsic program for matrix remodeling and CAF recruitment in slow growing, poor prognosis colorectal cancers.Cancer Research · 2026
5. When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer DrugsInternational Journal of Molecular Sciences · 2026
6. Saruparib + androgen receptor pathway inhibitor (ARPI) + androgen deprivation therapy (ADT) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): The phase 1/2 PETRANHA trial.Journal of Clinical Oncology · 2026
7. Omics-Based Functional Fingerprinting of Nanoparticles in Cancer: Toward Predictive NanomedicineInternational Journal of Molecular Sciences · 2026
8. Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 studyFrontiers in Oncology · 2026
9. Post‐surgery level of circulating DNA in stage III colon cancer patients: Impact on the reliability of minimal residual disease detectionInternational Journal of Cancer · 2026
10. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathyJournal of Nephrology · 2009
11. Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric studyESMO Real World Data and Digital Oncology · 2026
12. Case report: A case of mast cell leukemia treated with avapritinib: from diagnostic challenge to transplantationFrontiers in Oncology · 2026
13. IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort癌症：英文版 · 2026
14. Does Vitamin D Supplementation Impact Fibromyalgia-Related Pain? A Systematic Review and Meta-AnalysisNutrients · 2025
15. The emerging role of left atrial strain in cardiovascular risk stratification for multiple myeloma patients undergoing carfilzomib therapyEuropean Heart Journal Supplements · 2025
16. A BCMA-mRNA vaccine is a promising therapeutic for multiple myelomaBlood · 2025
17. ERRα and HIF-1α Cooperate to Enhance Breast Cancer Aggressiveness and Chemoresistance Under Hypoxic ConditionsCancers · 2025
18. Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA StudyCancers · 2025
19. Post-surgery level of circulating DNA in stage III colon cancer patients: impact on the reliability of minimal residual disease detection2025
20. PSMA-targeted PET imaging for brain metastases from non-prostatic solid tumors: a systematic reviewFrontiers in Oncology · 2025